SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

Original reporting
Published Nov 9, 2026, 2:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 5:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote places fewer Medicare policies but earns more on each one — source image
Decision brief

The 30-second read

$SLQTNeutralMed
01

Why it matters

The earnings release introduces new data on policy volume, revenue, and profitability, offering traders fresh information to reassess valuation.

02

Market read

SelectQuote's Q1 numbers provide a mixed signal for the Medicare brokerage sector, with revenue pressure offset by margin gains and higher per‑policy commissions.

03

What to watch

The ongoing False Claims Act litigation could pose a longer‑term risk not fully reflected in the earnings numbers.

Relevance 8/10Novelty 8/10Timing: released today with Q1 earnings

Background

SelectQuote reported Q1 2027 results amid a shifting Medicare Advantage landscape, with several carriers exiting the market and commission structures changing.

Company-level read

Ticker impact

$SLQTNeutralHigh confidence
Context

Q1 2027 results show 18% fewer Medicare Advantage policies, revenue down to $280M, but higher per‑policy commission value and improved EBITDA margins.

Expected impact

likely modest downside as investors weigh lower top‑line against improving profitability metrics

Evidence & confidence

The earnings release provides fresh numbers; revenue fell 15% YoY, but adjusted EBITDA loss narrowed and per‑policy LTV rose 16%, creating a nuanced outlook.

Market effects

Higher Medicare commission values may benefit other brokers with tenured agents; reduced volume could pressure peers reliant on volume.

U.S. health‑insurance brokerage sector sees mixed signals; investors may re‑price earnings expectations.

Limited to U.S. Medicare broker market; no broader global effect.

Counterpoint

Margin improvements could outweigh revenue decline, suggesting a potential bounce if the market overreacts to top‑line weakness.

Key entities

  • SelectQuote, Inc.

    U.S. Medicare brokerage listed on NYSE under SLQT.

  • Aetna

    Insurer mentioned for its commission policy changes.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMed

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

$SLQTMedAI 8/10

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.

Med

SelectQuote, Inc. Q1 2027 Earnings Call Summary

SelectQuote reported a $15M year-over-year adjusted EBITDA gain in Q1 2027, driven by a focus on profitability over volume. Healthcare Services margins increased 60% through member base optimization. Revenue declines in the Senior segment were planned. Management expects $60M operating cash flow in fiscal 2027 and a path to cash-paying preferred dividends by fiscal 2028. The Inflation Reduction Act impacted revenue but was offset by reimbursements.